Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

2-Year U.S. Treasury Note Continuous Contract $102.688 0.090 0.09% 5-Year U.S. Treasury Note Continuous Contract $106.664 0.164 0.15% 10-Year U.S. Treasury Note Continuous Contract $109.625 0.203 ...

Nasdaq provides the last-five real-time quotes and sales data for ETFs. Real-time stock quotes can be used to help inform investors when researching potential investment opportunities.

U.S. stocks were trimming some of their early losses in afternoon trading on Tuesday. The Dow was losing nearly 250 points, or 0.6%, at 44,050 after hitting a session low of 43,909. The Nasdaq ...

Research Chief Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of ...

Tracey looked at the list so you wouldn’t have to. She picked out the five must-see earnings charts this week. They are all fan favorites but several have excellent earnings surprise track ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Stocks rallied as investors digested Donald Trump's victory in the US presidential election over Kamala Harris.

Citi says Chart Industries (GTLS) shares have surged post earnings following the company’s strong margin and free cash flow performance, while management indicated that book/bill should be above ...

CARSON CITY, Nev., Nov. 04, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative ...

MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial ...

MIAMI, FL, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high ...